The Journal of Immunology, Vol 156, Issue 4 1661-1667, Copyright © 1996 by American Association of Immunologists

ARTICLES

Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease

WA Simmons, LY Leong, N Satumtira, GW Butcher, JC Howard, JA Richardson, CA Slaughter, RE Hammer and JD Taurog
Harold C. Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, Dallas 75235, USA.

Rats transgenic for the human MHC molecule HLA-B27 were used to study the effect of two alleles, cima and cimb, which are associated with peptide transport by the MHC-encoded Tap2 transporter, on the function of HLA-B27 as a restriction element for CTL recognition of the male H-Y minor H Ag and on the multisystem inflammatory disease characteristic of B27 transgenic rats. Anti-H-Y CTL generated in cima B27 transgenic rats lysed male B27 cimb/b targets significantly less well than cima/a or cima/b targets. Addition of exogenous H-Y peptides to male B27 cimb/b targets increased susceptibility to lysis to the level of cima/a targets. Male B27 cimb/b cells were less efficient than cima/a cells in competitively inhibiting CTL lysis of female B27 cima/a targets sensitized with exogenous H-Y peptides. 3H-Labeled peptides eluted from B27 molecules of lymphoblasts from rats of two cimb and three cima RT1 haplotypes showed that the cimb peptide pool favors comparatively longer and/or more hydrophobic peptides. These results indicate that RT1-linked Tap2 polymorphism in the rat strongly influences peptide loading of HLA-B27. Nonetheless, the prevalence and severity of multisystem inflammatory lesions were comparable in backcross rats bearing either cima/b or cimb/b. It thus appears either that binding of specific peptides to B27 is unimportant in the pathogenesis of B27- associated disease or that the critical peptides, unlike H-Y and many others, are not influenced by Tap transporter polymorphism.

This article has been cited by other articles:

				L. H. Boyle and J. S. Hill Gaston Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies Rheumatology, March 1, 2003; 42(3): 404 - 412. [Abstract] [Full Text] [PDF]

				A. B. Onderdonk, J. A. Richardson, R. E. Hammer, and J. D. Taurog Correlation of Cecal Microflora of HLA-B27 Transgenic Rats with Inflammatory Bowel Disease Infect. Immun., December 1, 1998; 66(12): 6022 - 6023. [Abstract] [Full Text] [PDF]

				M. Zhou, A. Sayad, W. A. Simmons, R. C. Jones, S. D. Maika, N. Satumtira, M. L. Dorris, S. J. Gaskell, R. S. Bordoli, R. Balfour Sartor, et al. The Specificity of Peptides Bound to Human Histocompatibility Leukocyte Antigen (HLA)-B27 Influences the Prevalence of Arthritis in HLA-B27 Transgenic Rats J. Exp. Med., September 7, 1998; 188(5): 877 - 886. [Abstract] [Full Text] [PDF]

				S. D. Khare, M. J. Bull, J. Hanson, H. S. Luthra, and C. S. David Spontaneous Inflammatory Disease in HLA-B27 Transgenic Mice Is Independent of MHC Class II Molecules: A Direct Role for B27 Heavy Chains and Not B27-Derived Peptides J. Immunol., January 1, 1998; 160(1): 101 - 106. [Abstract] [Full Text] [PDF]